US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AgomAb Therapeutics

8.65

-2.4500-22.07%

Post-market: 8.63-0.0200-0.23%18:13 EDT

Volume:639.28K

Turnover:6.09M

Market Cap:426.00M

PE:-1.92

High:11.32

Open:11.21

Low:8.56

Close:11.10

52wk High:17.82

52wk Low:8.56

Shares:49.25M

Float Shares:13.84M

Volume Ratio:5.13

T/O Rate:4.62%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.5143

EPS(LYR):-168.1598

ROE:-39.22%

ROA:-20.58%

PB:4.10

PE(LYR):-0.05

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Agomab’s ontunisertib shows positive results in Crohn’s Disease study

Agomab Reports Positive Topline Data from Stenova Open-Label Extension of Ontunisertib in Fibrostenosing Crohn’s Disease

Agomab Therapeutics Nv - Favorable Safety and Tolerability Profile Maintained Through 60 Weeks of Ontunisertib Treatment in Fscd

THOMSON REUTERS

Agomab Therapeutics Nv - Radiological Assessment Shows Trend for Fibrotic Stricture Stabilization During Treatment

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/AGMB"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"AGMB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGMB\",,,,,undefined,":{"symbol":"AGMB","market":"US","secType":"STK","nameCN":"AgomAb Therapeutics","latestPrice":8.65,"timestamp":1790884800000,"preClose":11.1,"halted":0,"volume":639276,"hourTrading":{"tag":"盘后","latestPrice":8.63,"preClose":8.65,"latestTime":"18:13 EDT","volume":107568,"amount":929636.970192,"timestamp":1790892780248,"change":-0.02,"changeRate":-0.002312,"amplitude":0.049711},"delay":0,"changeRate":-0.22072072072072066,"floatShares":13836000,"shares":49248000,"eps":-4.51426,"marketStatus":"Post-Mkt","change":-2.45,"latestTime":"10-01 18:13:25 EDT","open":11.21,"high":11.3224,"low":8.56,"amount":6094951.996848,"amplitude":0.248865,"askPrice":9.59,"askSize":100,"bidPrice":8.3,"bidSize":2,"shortable":0,"etf":0,"ttmEps":-4.51426,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790899200000},"marketStatusCode":4,"adr":0,"adrRate":1,"listingDate":1770354000000,"exchange":"NASDAQ","adjPreClose":11.1,"preHourTrading":{"tag":"盘前","latestPrice":11.5,"preClose":11.1,"latestTime":"09:06 EDT","volume":2185,"amount":25474.047554999997,"timestamp":1790860001633,"change":0.4,"changeRate":0.036036,"amplitude":0.087387},"postHourTrading":{"tag":"盘后","latestPrice":8.63,"preClose":8.65,"latestTime":"18:13 EDT","volume":107568,"amount":929636.970192,"timestamp":1790892780248,"change":-0.02,"changeRate":-0.002312,"amplitude":0.049711},"volumeRatio":5.134318},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGMB\",,,,,undefined,":{"symbol":"AGMB","floatShares":13836000,"roa":"-20.58%","roe":"-39.22%","lyrEps":-168.159829,"volumeRatio":5.134318,"shares":49248000,"dividePrice":0,"high":11.3224,"amplitude":0.248865,"preClose":11.1,"low":8.56,"week52Low":8.56,"pbRate":"4.10","week52High":17.82,"institutionHeld":0,"latestPrice":8.65,"committee":-0.960784,"eps":-4.51426,"divideRate":0,"volume":639276,"delay":0,"ttmEps":-4.51426,"open":11.21,"prevYearClose":16,"prevWeekClose":10.51,"prevMonthClose":11.1,"prevQuarterClose":11.1,"fiveDayClose":10.58,"twentyDayClose":13.66,"sixtyDayClose":12.74},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AGMB\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AGMB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AGMB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":8,"updateTime":1787716800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AGMB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AGMB","date":"2026-09-30","current":-1.91615,"percent":0.950311,"low":-14.725744,"twenty":-11.126198,"median":-8.776817,"eighty":-7.627138,"high":-6.52172,"avg":-9.433798,"sd":2.193394,"marketCap":518581176},"quantilePoints":[{"date":"2026-02-06","current":-14.293959,"twenty":-14.293959,"median":-14.293959,"eighty":-14.293959,"marketCap":779788464},{"date":"2026-02-13","current":-13.901135,"twenty":-14.202947,"median":-13.85921,"eighty":-13.805127,"marketCap":763217959},{"date":"2026-02-20","current":-13.975141,"twenty":-14.020702,"median":-13.811207,"eighty":-13.436782,"marketCap":760781120},{"date":"2026-02-27","current":-14.297833,"twenty":-14.274685,"median":-13.837477,"eighty":-13.631029,"marketCap":780275831},{"date":"2026-03-06","current":-12.944797,"twenty":-14.315694,"median":-13.869306,"eighty":-13.479283,"marketCap":692549629},{"date":"2026-03-13","current":-12.71107,"twenty":-14.294734,"median":-13.805127,"eighty":-12.961754,"marketCap":677928595},{"date":"2026-03-20","current":-11.600011,"twenty":-14.274685,"median":-13.584093,"eighty":-12.695924,"marketCap":618957093},{"date":"2026-03-27","current":-10.84065,"twenty":-14.216331,"median":-13.160447,"eighty":-12.395453,"marketCap":578505566},{"date":"2026-04-02","current":-10.748527,"twenty":-14.066263,"median":-13.052487,"eighty":-11.414439,"marketCap":574119256},{"date":"2026-04-10","current":-9.193391,"twenty":-13.930737,"median":-12.827934,"eighty":-10.709469,"marketCap":497602513},{"date":"2026-04-17","current":-10.018749,"twenty":-13.86294,"median":-12.650405,"eighty":-9.901184,"marketCap":545851924},{"date":"2026-04-24","current":-9.622204,"twenty":-13.825362,"median":-12.457995,"eighty":-9.650988,"marketCap":521483535},{"date":"2026-05-01","current":-7.206485,"twenty":-13.809991,"median":-11.744798,"eighty":-9.486381,"marketCap":528794052},{"date":"2026-05-08","current":-7.639457,"twenty":-13.779732,"median":-11.111376,"eighty":-9.258769,"marketCap":562411874},{"date":"2026-05-15","current":-7.446972,"twenty":-13.702513,"median":-10.748527,"eighty":-8.300034,"marketCap":543697644},{"date":"2026-05-22","current":-7.434647,"twenty":-13.568448,"median":-10.364346,"eighty":-8.115636,"marketCap":538772846},{"date":"2026-05-29","current":-7.796965,"twenty":-13.4527,"median":-9.998785,"eighty":-7.794875,"marketCap":568321631},{"date":"2026-06-05","current":-8.053102,"twenty":-13.287949,"median":-9.784729,"eighty":-7.758816,"marketCap":585558422},{"date":"2026-06-12","current":-6.750851,"twenty":-13.127527,"median":-9.578953,"eighty":-7.536224,"marketCap":486569993},{"date":"2026-06-18","current":-6.929006,"twenty":-13.073014,"median":-9.501773,"eighty":-7.448225,"marketCap":497404547},{"date":"2026-06-26","current":-9.2886,"twenty":-13.035188,"median":-9.467948,"eighty":-7.458553,"marketCap":661400304},{"date":"2026-07-02","current":-8.166663,"twenty":-12.965993,"median":-9.467948,"eighty":-7.479819,"marketCap":584573463},{"date":"2026-07-10","current":-8.975013,"twenty":-12.944797,"median":-9.309036,"eighty":-7.532768,"marketCap":641701114},{"date":"2026-07-17","current":-8.479177,"twenty":-12.71107,"median":-9.193391,"eighty":-7.541408,"marketCap":606735052},{"date":"2026-07-24","current":-8.981683,"twenty":-12.707304,"median":-9.020605,"eighty":-7.554336,"marketCap":638746235},{"date":"2026-07-31","current":-8.723327,"twenty":-12.661785,"median":-8.978348,"eighty":-7.610114,"marketCap":628157921},{"date":"2026-08-07","current":-9.22434,"twenty":-12.557349,"median":-9.00807,"eighty":-7.636377,"marketCap":664847662},{"date":"2026-08-14","current":-8.931525,"twenty":-12.519309,"median":-9.035172,"eighty":-7.716456,"marketCap":686763011},{"date":"2026-08-21","current":-8.496488,"twenty":-12.423423,"median":-8.981683,"eighty":-7.781927,"marketCap":661400304},{"date":"2026-08-28","current":-8.778373,"twenty":-12.380686,"median":-8.974146,"eighty":-7.796268,"marketCap":681591974},{"date":"2026-09-04","current":-9.428222,"twenty":-12.300242,"median":-8.931525,"eighty":-7.867232,"marketCap":730347469},{"date":"2026-09-11","current":-8.858281,"twenty":-11.959423,"median":-8.973278,"eighty":-7.956453,"marketCap":686516771},{"date":"2026-09-18","current":-7.774516,"twenty":-11.657926,"median":-8.880371,"eighty":-7.795572,"marketCap":594915538},{"date":"2026-09-25","current":-6.876368,"twenty":-11.321652,"median":-8.807045,"eighty":-7.758992,"marketCap":521043575},{"date":"2026-09-30","current":-6.851652,"twenty":-11.126198,"median":-8.776817,"eighty":-7.627138,"marketCap":518581176}],"updateTime":1790892805870},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AGMB\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672595097","title":"Agomab’s ontunisertib shows positive results in Crohn’s Disease study","url":"https://stock-news.laohu8.com/highlight/detail?id=2672595097","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672595097?lang=en_us&edition=fundamental","pubTime":"2026-10-01 18:35","pubTimestamp":1790850909,"startTime":"0","endTime":"0","summary":"Agomab (AGMB) announced positive results of the 48-week OLE portion of the Phase 2a STENOVA trial evaluating ontunisertib in patients with Fibroste...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/agomabs-ontunisertib-shows-positive-results-in-crohns-disease-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/agomabs-ontunisertib-shows-positive-results-in-crohns-disease-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","AGMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672775670","title":"Agomab Reports Positive Topline Data from Stenova Open-Label Extension of Ontunisertib in Fibrostenosing Crohn’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2672775670","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672775670?lang=en_us&edition=fundamental","pubTime":"2026-10-01 18:30","pubTimestamp":1790850641,"startTime":"0","endTime":"0","summary":"Agomab reports positive topline data from STENOVA open-label extension of ontunisertib in fibrostenosing Crohn’s diseaseAgomab Therapeutics NV reported positive topline results from a long-term extens","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL2450cg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00B64PRP62.GBP","SG9999014013.SGD","BK4585","IE00BQXX3F31.USD","AGMB","BK4112","IE00BGHQF748.EUR","IE00BQXX3C00.GBP","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","BCDF","LU2210149790.SGD","IE00BKPKM429.USD","BK4007","IE00BN0W2V16.EUR","SG9999014039.USD","IE00BQXX3D17.EUR","NDAQ","LU0314104364.USD","SG9999014021.USD","IE00BN0W2T93.GBP","LU2210150020.SGD","SG9999014005.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672756771","title":"Agomab Therapeutics Nv - Favorable Safety and Tolerability Profile Maintained Through 60 Weeks of Ontunisertib Treatment in Fscd","url":"https://stock-news.laohu8.com/highlight/detail?id=2672756771","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672756771?lang=en_us&edition=fundamental","pubTime":"2026-10-01 18:30","pubTimestamp":1790850606,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45N0O4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AGMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672567237","title":"Agomab Therapeutics Nv - Radiological Assessment Shows Trend for Fibrotic Stricture Stabilization During Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2672567237","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672567237?lang=en_us&edition=fundamental","pubTime":"2026-10-01 18:30","pubTimestamp":1790850606,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45N0O4:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AGMB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":13,"pageCount":1,"totalSize":50,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/AGMB\",params:#limit:6,delay:false,,,undefined,":[]}}